Scott J. Rodig
Brigham and Women's Hospital
Affiliation Brigham and Women’s Hospital Top Publications PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma (2014) – 3,603 citations An immunogenic personal neoantigen vaccine for patients with melanoma (2017) – 3,036 citations Comprehensive analyses of tumor immunity: implications for cancer immunotherapy (2016) – 2,803 citations Subsets of exhausted CD8+ T cells differentially mediate ... <a title="Scott J. Rodig" class="read-more" href="https://journalsworld.com/researchers/scott-j-rodig/" aria-label="Read more about Scott J. Rodig">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
Brigham and Women's Hospital
Top Publications
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (2014) - 3,603 citations
- An immunogenic personal neoantigen vaccine for patients with melanoma (2017) - 3,036 citations
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy (2016) - 2,803 citations
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade (2019) - 2,205 citations
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) - 2,034 citations
At a glance
- Full name
- Scott J. Rodig
- ORCID
- 0000-0003-1761-9769
- OpenAlex ID
- https://openalex.org/A5058975989
Research interests
- Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma ↗2014 · New England Journal of Medicine3,603OpenAlex citations
- 3,036OpenAlex citations
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy ↗2016 · Genome biology2,803OpenAlex citations
- 2,205OpenAlex citations
- 2,034OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma ↗2014 · New England Journal of Medicine
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy ↗2016 · Genome biology
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:19:15
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.